TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

ESKAYEF

Pharmaceuticals
Generics

ESKAYEF is a generic drug manufacturer with 2 FDA-approved products.

2022
Since
2
Drugs
-
Trials
68
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

PREGABALIN 2026-02-24
PREGABALIN 2026-02-23
Labeling
PREGABALIN 2026-02-23
Labeling
PREGABALIN 2026-02-23
Labeling
PREGABALIN 2026-02-03
Labeling
PREGABALIN 2026-02-02
Labeling
PREGABALIN 2026-02-02
Labeling
PALIPERIDONE 2026-01-26
PREGABALIN 2025-12-29
Labeling
PREGABALIN 2025-10-01
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

No indication data

Pipeline Strength Pro

Loading...